QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Determination of DP-VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC-MS/MS: A clinical pharmacokinetics and excretion study 期刊论文 DRUG TESTING AND ANALYSIS, 2019, 卷号: 11, 期号: 7 作者:  Li, Yi;  Zhan, Huizhong;  Fan, Yaxin;  Zhang, Jing;  Cao, Guoying 收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05 DP-VPA  epilepsy  excretion  pharmacokinetics  UPLC-MS  MS   HS016, A PROPOSED ADALIMUMAB BIOSIMILAR, SHOWED EQUIVALENT PHARMACOKINETICS AND SIMILAR SAFETY, IMMUNOGENICITY AND TOLERABILITY TO CHINA-LICENSED ADALIMUMAB IN HEALTHY MALE SUBJECTS, ACCORDING TO A 2.3-MONTHS PHASE I STUDY 会议论文 作者:  Cao, Guoying;  Yu, Jicheng;  Wang, Jingjing;  Yang, Xiaoli;  Xue, Yu 收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05 Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis 期刊论文 CLINICAL THERAPEUTICS, 2019, 卷号: 41, 期号: 6 作者:  Wu, Junzhen;  Wu, Hailan;  Wang, Yu 收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05 contezolid  MRX-I  pharmacokinetic-pharmacodynamic  pharmacokinetics  supra-therapeutic doses  tolerability   Determination of DP-VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC-MS/MS: a clinical pharmacokinetics and excretion study. 期刊论文 Drug testing and analysis, 2019 作者:  Yi Li;  Huizhong Zhan;  Yaxin Fan;  Jing Zhang;  Guoying Cao 收藏  |  浏览/下载：24/0  |  提交时间：2019/12/17 DP-VPA  UPLC-MS/MS  epilepsy  excretion  pharmacokinetics  valproic acid   Climate change has weakened the ability of Chinese lakes to bury polycyclic aromatic hydrocarbons 期刊论文 ENVIRONMENTAL POLLUTION, 2019, 卷号: 255 作者:  Tao, Yuqiang;  Zhang, Ya;  Cao, Jicheng;  Wu, Zifan;  Yao, Shuchun 收藏  |  浏览/下载：34/0  |  提交时间：2020/09/16